The Analgesic Effect of Abobotulinum and Incobotulinum Toxins Type A in Central Poststroke Pain: Two Case Reports

The International Association for the Study of Pain defines central pain as “pain initiated or caused by primary lesion or dysfunction of the central nervous system” [1]. If it results from a stroke, it is referred to as central poststroke pain (CPSP) [1]. CPSP prevalence reports vary from 8% to 46% [3-5]. This wide variation is possibly related to the heterogeneity of stroke lesions between the populations surveyed, differences in study design, and different timing of evaluations after stroke [6].

Source: PM and R - December 12, 2015 Category: Rehabilitation Authors: Alexandre Andre Gaspar de Camoes-Barbosa, Ana-Filipa Neves Tags: Case Presentation Source Type: research